Chemotactic Mediators of Th1 T-cell Trafficking in Smokers and COPD Patients

REFERENCES

• Viegi G, Scognamiglio A, Baldacci S, Pistelli F, Carrozzi L. Epidemiology of chronic obstructive pulmonary disease (COPD). Respiration 2001; 68(1)4–19
   PubMed Web of Science ®Google Scholar
• Barnes P J. Mediators of chronic obstructive pulmonary disease. Pharmacol Rev 2004; 56(4)515–548
   PubMed Web of Science ®Google Scholar
• Hodge S, Hodge G, Holmes M, Reynolds P N. Increased airway epithelial and T-cell apoptosis in COPD remains despite smoking cessation. Eur Respir J 2005; 25(3)447–454
   PubMed Web of Science ®Google Scholar
• Hodge G, Nairn J, Holmes M, Reynolds P N, Hodge S. Increased intracellular T helper 1 proinflammatory cytokine production in peripheral blood, bronchoalveolar lavage and intraepithelial T cells of COPD subjects. Clin Exp Immunol 2007; 150(1)22–29
   PubMed Web of Science ®Google Scholar
• Majo J, Ghezzo H, Cosio M G. Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema. Eur Respir J 2001; 17(5)946–953
   PubMed Web of Science ®Google Scholar
• Finkelstein R, Fraser R S, Ghezzo H, Cosio M G. Alveolar inflammation and its relation to emphysema in smokers. Am J Respir Crit Care Med 1995; 152: 1666–1672, (5 Pt 1)
   PubMed Web of Science ®Google Scholar
• Hodge S, Hodge G, Nairn J, Holmes M, Reynolds P N. Increased airway granzyme b and perforin in current and ex-smoking COPD subjects. COPD J Chron Obstruct Pulmon Dis 2006; 3: 1–9
   Google Scholar
• Hodge S, Hodge G, Flower R, Han P. Surface activation markers of T lymphocytes: role in the detection of infection in neonates. Clin Exp Immunol 1998; 113(1)33–38
   PubMed Web of Science ®Google Scholar
• Keatings V M, Collins P D, Scott D M, Barnes P J. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996; 153: 530–534
   PubMed Web of Science ®Google Scholar
• Traves S L, Culpitt S V, Russell R E, Barnes P J, Donnelly L E. Increased levels of the chemokines GROalpha and MCP-1 in sputum samples from patients with COPD. Thorax 2002; 57(7)590–595
   PubMed Web of Science ®Google Scholar
• Tanino M, Betsuyaku T, Takeyabu K, Tanino Y, Yamaguchi E, Miyamoto K, Nishimura M. Increased levels of interleukin-8 in BAL fluid from smokers susceptible to pulmonary emphysema. Thorax 2002; 57(5)405–411
   PubMed Web of Science ®Google Scholar
• Hall Z, Barnes P J, Donnely L E. Alveolar macrophage production of CXCR3 chemokines. Am J Respir Crit Care Med 2004; 169: A169
   Google Scholar
• Saetta M, Mariani M, Panina-Bordignon P, Turato G, Buonsanti C, Baraldo S, Bellettato C M, Papi A, Corbetta L, Zuin R, et al. Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 165(10)1404–1409
   PubMed Web of Science ®Google Scholar
• Grumelli S, Corry D B, Song L Z, Song L, Green L, Huh J, Hacken J, Espada R, Bag R, Lewis D E, et al. An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema. PLoS Med 2004; 1(1)e8
   PubMed Web of Science ®Google Scholar
• Fabbri L M, Hurd S S. Global Strategy for the Diagnosis, Management and Prevention of COPD: 2003 update. Eur Respir J 2003; 22(1)1–2
   PubMed Web of Science ®Google Scholar
• Hodge S J, Hodge G L, Holmes M, Reynolds P N. Flow cytometric characterization of cell populations in bronchoalveolar lavage and bronchial brushings from patients with chronic obstructive pulmonary disease. Cytometry B Clin Cytom 2004; 61(1)27–34
   PubMedGoogle Scholar
• Han P, Hodge G, Story C, Xu X. Phenotypic analysis of functional T-lymphocyte subtypes and natural killer cells in human cord blood: relevance to umbilical cord blood transplantation. Br J Haematol 1995; 89(4)733–740
   PubMed Web of Science ®Google Scholar
• Hodge G, Hodge S, Haslam R, McPhee A, Sepulveda H, Morgan E, Nicholson I, Zola H. Rapid simultaneous measurement of multiple cytokines using 100 microl sample volumes—association with neonatal sepsis. Clin Exp Immunol 2004; 137(2)402–407
   PubMed Web of Science ®Google Scholar
• Traves S L, Donnelly L E. Chemokines and their receptors as targets for the treatment of COPD. Curr Respir Med Rev 2005; 1: 15–32
   Google Scholar
• Kanegane H, Tosato G. Activation of naive and memory T cells by interleukin-15. Blood 1996; 88(1)230–235
   PubMed Web of Science ®Google Scholar
• Oughton J A, Kerkvliet N I. Novel phenotype associated with in vivo activated CTL precursors. Clin Immunol 1999; 90(3)323–333
   PubMed Web of Science ®Google Scholar
• de Jong J W, van der Belt-Gritter B, Koeter G H, Postma D S. Peripheral blood lymphocyte cell subsets in subjects with chronic obstructive pulmonary disease: association with smoking, IgE and lung function. Respir Med 1997; 91(2)67–76
   PubMed Web of Science ®Google Scholar
• Rutgers S R, Timens W, Kaufmann H F, van der Mark T W, Koeter G H, Postma D S. Comparison of induced sputum with bronchial wash, bronchoalveolar lavage and bronchial biopsies in COPD. Eur Respir J 2000; 15(1)109–115
   PubMed Web of Science ®Google Scholar
• Tzanakis N, Chrysofakis G, Tsoumakidou M, Kyriakou D, Tsiligianni J, Bouros D, Siafakas N M. Induced sputum CD8+ T-lymphocyte subpopulations in chronic obstructive pulmonary disease. Respir Med 2004; 98(1)57–65
   PubMed Web of Science ®Google Scholar
• Keatings V M, Collins P D, Scott D M, Barnes P J. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996; 153(2)530–534
   PubMed Web of Science ®Google Scholar
• Traves S L, Smith S J, Barnes P J, Donnelly L E. Specific CXC but not CC chemokines cause elevated monocyte migration in COPD: a role for CXCR2. J Leukoc Biol Aug, 2004; 76(2)441–450
   PubMed Web of Science ®Google Scholar
• Sethi S, Murphy T F. Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review. Clin Microbiol Rev 2001; 14(2)336–363
   PubMed Web of Science ®Google Scholar
• Jeffery P K. Lymphocytes, chronic bronchitis and chronic obstructive pulmonary disease. Novartis Found Symp 2001; 234: 149–161
   PubMed Web of Science ®Google Scholar
• Ritter M, Goggel R, Chaudhary N, Wiedenmann A, Jung B, Weith A, Seither P. Elevated expression of TARC (CCL17) and MDC (CCL22) in models of cigarette smoke-induced pulmonary inflammation. Biochem Biophys Res Commun 2005; 334(1)254–262
   PubMed Web of Science ®Google Scholar
• Ogilvie P, Bardi G, Clark-Lewis I, Baggiolini M, Uguccioni M. Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5. Blood 2001; 97(7)1920–1924
   PubMed Web of Science ®Google Scholar
• Hornung F, Scala G, Lenardo M J. TNF-α induced secretion of C-C chemokines modulates CC chemokine receptor 5 expression on peripheral blood monocytes. J Immunol 2000; 164: 6180–6187
   PubMed Web of Science ®Google Scholar